2013 American Transplant Congress
Is Evaluation of Incidental Adrenal Lesions in Living Renal Donors Necessary?
Introduction: The purpose of the study was to evaluate the prevalence and significance of incidental adrenal lesions identified in potential living renal donors.Methods: The medical…2013 American Transplant Congress
Actuarial Perspective on the Annual Per Patient Maintenance Immunosuppressive Medication Costs for Transplant Recipients: 1993-2011, An
United Network for the Recruitment of Transplantation Professionals, Rochester, MN
The annual per patient cost of immunosuppressive medications for transplant recipients is highly variable, and poorly understood.Since 1993, insurance actuaries have periodically published estimates of…2013 American Transplant Congress
Long-Term Assessment of Function in Patients Completing the Spare-the-Nephron Study with a Functioning Graft
Div of Nephrology, Dept of Medicine, Univ of Maryland School of Medicine, Baltimore, MD
In the Spare-the-Nephron (STN) study (Weir MR et al. Kidney Int 2011;79:897-907) kidney transplant recipients randomized about 115 days post-transplant to convert from CNI (calcineurin…2013 American Transplant Congress
Tolerance Requires Unique Remodeling of Lymph Node Structure and Stromal Fibers
University of Maryland, Baltimore
Background: Immunity and tolerance are regulated by changes in secondary lymphoid organ (SLO) structure and function. SLO structural elements include the fibers ER-TR7, desmin, and…2013 American Transplant Congress
Impact of Genetic Polymorphisms of FcγRIIa, FcγRIIIa and C1qA on Infectious Complications after Liver Transplantation, The
Hirosihma University, Hiroshima, Japan
Background:Infection is one of the leading causes of morbidity and mortality in liver transplant (LT) recipients. Since the immunosuppressive regimen currently used after LT reduces…2013 American Transplant Congress
MELD Score Does Not Predict Outcome of Living Donor Liver Transplantation
BackgroundLiving donor liver transplantation (LDLT) is the established treatment for the patients with end stage liver disease. Model for End-stage Liver Disease (MELD) score is…2013 American Transplant Congress
New Outlook on HLA-DQ Antigen/Antibody Interactions, A
Comprehensive Transplant Center, Northwestern University, Chicago, IL
The role of HLA-DQ antibodies in decreasing solid organ graft outcome has recently been described. It is not clear, however, why HLA-DQ has different effects…2013 American Transplant Congress
Impact of Type I and Type II Diabetes on BK Nephropathy and Pancreas Transplant Outcomes, The
Transplant, MUSC, Charleston, SC
Background: Pancreas transplant (PTX) improves quality of life and survival for patients irrespective of pre-PTX c-peptide. Little consideration has been afforded to BK nephropathy (BKN)…2013 American Transplant Congress
Post Transplant Outcomes in Elderly Renal Transplant Recipients
Nephrology, Henry Ford Hospital, Detroit, MI
The choice of induction therapy in elderly renal transplant population is generally based on experience from general renal transplant recipient (RTR) population. It is uncertain…2013 American Transplant Congress
Essential Role of CBP in Maintaining Foxp3 Stability during Inflammatory Events
CD4+ T-regulatory (Treg) cells maintain self-tolerance and control immune responses to nonself-antigens, and thereby limit excessive inflammation. High level and stable expression of Foxp3 transcription…
- « Previous Page
- 1
- …
- 165
- 166
- 167
- 168
- 169
- …
- 178
- Next Page »